tasimelteon

FDA Drug Profile — Hetlioz LQ, Hetlioz

Drug Details

Generic Name
tasimelteon
Brand Names
Hetlioz LQ, Hetlioz
Application Number
NDA214517
Sponsor
Vanda Pharmaceuticals Inc.
NDC Codes
2
Dosage Forms
SUSPENSION, CAPSULE
Routes
ORAL
Active Ingredients
TASIMELTEON

Indications and Usage

1 INDICATIONS AND USAGE Tasimelteon capsules are a melatonin receptor agonist. Tasimelteon capsules are indicated for the treatment of Non ­24-Hour Sleep-Wake Disorder (Non-24) in adults ( 1 ) 1.1 Non-24-Hour Sleep-Wake Disorder (Non-24) Tasimelteon capsules are indicated for the treatment of Non-24 in adults.